Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

HitGen to Discover Small Molecule Leads for India's Sun Pharma Unit

publication date: Mar 14, 2019

HitGen of Chengdu will collaborate with India's Sun Pharma Advanced Research Company to discover small molecule leads. HitGen will search its DNA-encoded library of leads, now numbering more than 400 billion novel, diverse, drug-like compounds. to discover lead molecules for SPARC. SPARC will make an upfront payment to HitGen and be responsible for additional milestone payments. HitGen has formed many discovery collaborations with the world's biopharmas, including most recently Biogen, Bayer and Genentech. More details....

Stock Symbol: (BSE: 532872)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events

ChinaBio Partnering Forum 2020

Content Availbalble Until Dec. 21, 2020